Free Trial

ARK Genomic Revolution ETF (ARKG) News Today

$24.57
-0.48 (-1.92%)
(As of 06/17/2024 ET)
3 Biotech ETFs Overdue for a Bounce
ARK Genomic Revolution ETF
ARKG February 23rd Options Begin Trading
Tuesday's ETF Movers: ARKG, ARKF
ARK Genomic Revolution ETF (BATS:ARKG) Shares Sold by DDD Partners LLC
DDD Partners LLC lessened its holdings in shares of ARK Genomic Revolution ETF (BATS:ARKG - Free Report) by 9.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 164,472 shares of the company's stock after selling 17
Verve Therapeutics Gains 20.74% In June as Ark Funds Invest (ARKG)
Verve Therapeutics' efforts to eliminate cardiovascular disease through gene-editing treatments have momentum, as the stock gets a 20.74% boost in June.
Analysts Bullish On Exact Sciences' Advanced Cancer Screening (ARKG)
Exact Sciences sees a bump in stock price amid rising revenue and study results that show advancements to its flagship Cologuard colorectal screening product.
Tuesday's ETF Movers: SMH, ARKG
Friday's ETF Movers: ARKG, COPX
Thursday's ETF Movers: ARKG, OIH
Friday's ETF Movers: ARKG, GDXJ
Tuesday's ETF Movers: REMX, ARKG
Best Bond Funds
ARKG ARK Genomic Revolution ETF
Why a Biotech ETF Might Cure Your Portfolio in 2023
Wednesday's ETF Movers: ARKG, LIT
Investing in Genetic Sequencing Stocks
Get ARK Genomic Revolution ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARKG and its competitors with MarketBeat's FREE daily newsletter.

Bigger Than NVIDIA? (Ad)

With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ONE stock you should be watching.

Get the full story here >>>

ARKG Media Mentions By Week

ARKG Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ARKG
News Sentiment

0.00

1.09

Average

News Sentiment

ARKG News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ARKG Articles
This Week

1

0

ARKG Articles
Average Week

Get ARK Genomic Revolution ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARKG and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (BATS:ARKG) was last updated on 6/17/2024 by MarketBeat.com Staff

From Our Partners